A detailed history of Samsara Bio Capital, LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 1,562,500 shares of INZY stock, worth $4.7 Million. This represents 4.74% of its overall portfolio holdings.

Number of Shares
1,562,500
Previous 1,562,500 -0.0%
Holding current value
$4.7 Million
Previous $6.97 Million 17.26%
% of portfolio
4.74%
Previous 3.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.09 - $7.0 $6.39 Million - $10.9 Million
1,562,500 New
1,562,500 $6.56 Million
Q2 2023

Aug 14, 2023

SELL
$4.93 - $6.74 $2.49 Million - $3.4 Million
-504,407 Closed
0 $0
Q1 2023

May 15, 2023

BUY
$1.3 - $5.73 $655,729 - $2.89 Million
504,407 New
504,407 $2.89 Million

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $121M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.